Pharmacology

  • Vanderbilt University

    Vanderbilt mourns loss of renowned clinical pharmacologist Jackson Roberts II, MD

    Jackson Roberts II, MD, an internationally known clinical pharmacologist in the Vanderbilt University School of Medicine who helped define the role of lipid peroxidation and oxidative stress in human disease, died May 31 in Nashville. He was 79. Dr. Roberts, professor of Pharmacology and Medicine, emeritus, was perhaps best known… Read More

    Jun. 6, 2023

  • Lindsley are among four faculty working in the Vanderbilt Warren Center for Neuroscience Drug Discovery on a new drug, VU319, to treat Alzheimer's disease.

    Lindsley named 2022 fellow of American Society for Pharmacology and Experimental Therapeutics

    Craig W. Lindsley, University Distinguished Professor of Pharmacology, Biochemistry and Chemistry, who holds the William K. Warren, Jr. Chair in Medicine, was recently announced as a 2022 fellow of the American Society for Pharmacology and Experimental Therapeutics for his demonstrated excellence and… Read More

    Nov. 30, 2022

  • Headshot of Al Reynolds.

    Basic Sciences mourns the loss of Reynolds

    By Leah Mann Graduate student Sarah Kurley with thesis advisor Al Reynolds. (Photo by Mary Donaldson) Albert “Al” Reynolds, celebrated and respected professor of pharmacology, emeritus, passed away earlier in November. He had retired in August after 26 years at Vanderbilt University. In the nearly three decades of Reynolds’ affiliation… Read More

    Nov. 15, 2022

  • Vanderbilt University

    Nanoparticles boost anti-cancer immunity

    The growth of epithelial ovarian cancer, one of the most lethal malignancies, is associated with the presence of tumor-associated macrophages (TAMs), white blood cells that can block the anti-cancer activity of the immune system and immunotherapy. Fortunately, TAMs can be “repolarized,” converted from immunosuppressive tumor-promoters to inflammatory tumor-fighters. Now,… Read More

    Aug. 18, 2022

  • Vanderbilt University

    Mass spectrometry analysis reveals massive insight into neuronal signaling

    Heidi Hamm, Yun Young Yim By Emily Overway Researchers in the lab of Heidi Hamm, a professor of pharmacology who also holds the Aileen M. Lange and Annie Mary Lyle Chair in Cardiovascular Research, recently published a paper exploring the G protein subunits that interact with the SNARE complex. The… Read More

    Mar. 3, 2022

  • Vanderbilt University

    CD40 expression correlates with response to immunotherapy in melanoma patients

    L-R: Ann Richmond, Chi Yan By Wendy Bindeman Ann Richmond, professor of pharmacology, and Chi Yan, a research assistant professor in the Richmond lab, recently published a study showing that expression of a protein called CD40 can be used to predict response to immunotherapy in malignant melanoma. Read More

    Mar. 1, 2022

  • Vanderbilt University

    Richard Sando awarded 2022 Sloan Research Fellowship in neuroscience

    Richard Sando, assistant professor of pharmacology, has been selected to receive a 2022 Sloan Research Fellowship, one of the most competitive and prestigious awards available to early-career researchers. The fellowships, awarded annually by the Alfred P. Sloan Foundation, honor extraordinary U.S. and Canadian scientists and scholars… Read More

    Feb. 16, 2022

  • Vanderbilt University

    Vanderbilt researchers discover new spontaneous signaling pathway in the brain

    The brain is constantly firing and controlling purposeful action potentials—electronic messages used by neurons to communicate with each other and allow the brain to function. Conversely, the way spontaneous neural communication happens in the brain has been found to make use of a different process. Ege Kavalali, William Stokes Chair in Experimental… Read More

    Feb. 14, 2022

  • Vanderbilt University

    Ege Kavalali to lead pharmacology department in School of Medicine Basic Sciences

    Ege T. Kavalali, William Stokes Professor of Experimental Therapeutics, has been named chair of the Department of Pharmacology in Vanderbilt University School of Medicine Basic Sciences. National leaders in pharmacology, members of the pharmacology department at Vanderbilt and Lawrence J. Marnett, dean… Read More

    Feb. 4, 2022

  • Vanderbilt University

    New target identified for rapid antidepressant drugs

    THE IDEA Vanderbilt researchers found that ketamine’s rapid antidepressant action is due to specific synaptic effects. This represents a new target for drug development that could fill a major gap in care for depression. Ege Kavalali (Vanderbilt University) Lisa Monteggia (John Russell/Vanderbilt University) The research was led by… Read More

    Nov. 10, 2021